Dolby Laboratories [DLB] vs Copart [CPRT] Detailed Stock Comparison
Dolby Laboratories
NYSE
Loading...
Copart
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Dolby Laboratories wins in 11 metrics, Copart wins in 8 metrics, with 0 ties. Dolby Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dolby Laboratories | Copart | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.30 | 28.37 | Dolby Laboratories |
| Price-to-Book Ratio | 2.62 | 4.75 | Dolby Laboratories |
| Debt-to-Equity Ratio | 1.50 | 1.13 | Copart |
| PEG Ratio | 1.31 | 1.38 | Dolby Laboratories |
| EV/EBITDA | 16.42 | 42.24 | Dolby Laboratories |
| Profit Margin (TTM) | 19.62% | 33.41% | Copart |
| Operating Margin (TTM) | 14.92% | 36.78% | Copart |
| EBITDA Margin (TTM) | 14.92% | 36.78% | Copart |
| Return on Equity | 10.50% | 18.48% | Copart |
| Return on Assets (TTM) | 5.86% | 11.84% | Copart |
| Free Cash Flow (TTM) | $297.25M | $1.23B | Copart |
| 1-Year Return | -1.88% | -20.51% | Dolby Laboratories |
| Price-to-Sales Ratio (TTM) | 5.07 | 9.39 | Dolby Laboratories |
| Enterprise Value | $6.18B | $82.64B | Copart |
| EV/Revenue Ratio | 4.59 | 17.79 | Dolby Laboratories |
| Gross Profit Margin (TTM) | 86.06% | 45.30% | Dolby Laboratories |
| Revenue per Share (TTM) | $14 | $5 | Dolby Laboratories |
| Earnings per Share (Diluted) | $2.71 | $1.59 | Dolby Laboratories |
| Beta (Stock Volatility) | 0.92 | 1.03 | Dolby Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Dolby Laboratories vs Copart Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dolby Laboratories | -3.76% | 0.33% | -0.85% | -2.77% | 3.73% | -6.58% |
| Copart | -0.54% | -0.34% | -8.82% | -8.97% | -18.02% | -21.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dolby Laboratories | -1.88% | 13.05% | 5.41% | 107.10% | 18.57% | 362.87% |
| Copart | -20.51% | 64.87% | 51.71% | 924.19% | 1,977.10% | 2,965.52% |
News Based Sentiment: Dolby Laboratories vs Copart
Dolby Laboratories
News based Sentiment: POSITIVE
Dolby Laboratories delivered a strong Q3, exceeding expectations and raising its full-year guidance. Analyst sentiment has also improved significantly, with multiple upgrades and increased price targets. While insider selling remains a concern, the overall narrative is positive, suggesting continued growth potential for the company.
Copart
News based Sentiment: MIXED
Copart delivered a solid Q3 earnings report with revenue growth, but the mixed analyst sentiment, insider selling, and a Zacks downgrade create a complex investment picture. The company's strategic investments and global expansion are positive, but require further monitoring to assess their impact.
Performance & Financial Health Analysis: Dolby Laboratories vs Copart
| Metric | DLB | CPRT |
|---|---|---|
| Market Information | ||
| Market Cap | $6.85B | $44.10B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 460,164 | 6,856,740 |
| 90 Day Avg. Volume | 513,518 | 7,689,460 |
| Last Close | $69.94 | $44.21 |
| 52 Week Range | $68.24 - $89.66 | $44.12 - $64.38 |
| % from 52W High | -21.99% | -31.33% |
| All-Time High | $104.74 (May 03, 2021) | $64.38 (Nov 25, 2024) |
| % from All-Time High | -33.23% | -31.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.05% |
| Quarterly Earnings Growth | 0.20% | 0.23% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.33% |
| Operating Margin (TTM) | 0.15% | 0.37% |
| Return on Equity (TTM) | 0.11% | 0.18% |
| Debt to Equity (MRQ) | 1.50 | 1.13 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.19 | $9.50 |
| Cash per Share (MRQ) | $7.30 | $2.47 |
| Operating Cash Flow (TTM) | $465.54M | $1.80B |
| Levered Free Cash Flow (TTM) | $375.60M | $869.61M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Dolby Laboratories vs Copart
| Metric | DLB | CPRT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.30 | 28.37 |
| Forward P/E | 18.70 | 25.93 |
| PEG Ratio | 1.31 | 1.38 |
| Price to Sales (TTM) | 5.07 | 9.39 |
| Price to Book (MRQ) | 2.62 | 4.75 |
| Market Capitalization | ||
| Market Capitalization | $6.85B | $44.10B |
| Enterprise Value | $6.18B | $82.64B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.59 | 17.79 |
| Enterprise to EBITDA | 16.42 | 42.24 |
| Risk & Other Metrics | ||
| Beta | 0.92 | 1.03 |
| Book Value per Share (MRQ) | $27.19 | $9.50 |
Financial Statements Comparison: Dolby Laboratories vs Copart
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DLB | CPRT |
|---|---|---|
| Revenue/Sales | $369.56M | $1.13B |
| Cost of Goods Sold | $35.84M | $615.38M |
| Gross Profit | $333.72M | $509.72M |
| Research & Development | $61.71M | N/A |
| Operating Income (EBIT) | $111.97M | $412.59M |
| EBITDA | $140.61M | $466.73M |
| Pre-Tax Income | $120.25M | $478.41M |
| Income Tax | $28.02M | $83.10M |
| Net Income (Profit) | $92.23M | $395.31M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DLB | CPRT |
|---|---|---|
| Cash & Equivalents | $626.55M | $2.78B |
| Total Current Assets | $1.39B | $5.75B |
| Total Current Liabilities | $457.49M | $683.28M |
| Long-Term Debt | $29.66M | $83.87M |
| Total Shareholders Equity | $2.58B | $9.21B |
| Retained Earnings | $2.60B | $8.09B |
| Property, Plant & Equipment | $264.92M | $99.71M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DLB | CPRT |
|---|---|---|
| Operating Cash Flow | $129.41M | $432.33M |
| Capital Expenditures | $-6.90M | $-60.34M |
| Free Cash Flow | $168.00M | $350.84M |
| Debt Repayment | N/A | $-5,000 |
| Common Stock Repurchase | $-36.51M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DLB | CPRT |
|---|---|---|
| Shares Short | 1.91M | 26.27M |
| Short Ratio | 4.18 | 3.89 |
| Short % of Float | 0.05% | 0.03% |
| Average Daily Volume (10 Day) | 460,164 | 6,856,740 |
| Average Daily Volume (90 Day) | 513,518 | 7,689,460 |
| Shares Outstanding | 95.39M | 967.48M |
| Float Shares | 60.48M | 1.78B |
| % Held by Insiders | 0.01% | 0.09% |
| % Held by Institutions | 0.98% | 0.87% |
Dividend Analysis & Yield Comparison: Dolby Laboratories vs Copart
| Metric | DLB | CPRT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |